• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多组学的铁死亡相关基因TXNIP在肺腺癌干细胞中的诊断及预测意义

Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics.

作者信息

Zheng Yuanyuan, Yang Wei, Wu Weixuan, Jin Feng, Lu Dehua, Gao Jing, Wang Shubin

机构信息

Department of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital, Shenzhen Peking University-Hong Kong University of Science & Technology Medical Center, Shenzhen 518036, China.

GeneMind Biosciences Company Limited, Shenzhen 518000, China.

出版信息

Transl Oncol. 2024 Jul;45:101926. doi: 10.1016/j.tranon.2024.101926. Epub 2024 Apr 13.

DOI:10.1016/j.tranon.2024.101926
PMID:38615437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11033204/
Abstract

BACKGROUND

Lung cancer stands as the foremost cause of cancer-related fatalities globally. The presence of cancer stem cells (CSCs) poses a challenge, rendering current targeted tumor therapies ineffective. This study endeavors to investigate a novel therapeutic approach focusing on ferroptosis and delves into the expression of ferroptosis-related genes within lung CSCs.

METHODS

We systematically examined RNA-seq datasets derived from lung tumor cells (LTCs) and lung cancer stem cells (LSCs), as previously investigated in our research. Our focus was on analyzing differentially expressed genes (DEGs) related to ferroptosis. Utilizing the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO), we conducted functional analysis of these ferroptosis-related DEGs. Additionally, we employed protein‒protein interaction networks to identify hub genes. LC‒MS/MS analysis of LTCs and LSCs was conducted to pinpoint the crucial ferroptosis-related gene-thioredoxin-interacting protein (TXNIP).Further, we delved into the immune cell infiltration landscape of LTCs and LSCs, examining the correlation between TXNIP and lung adenocarcinoma (LUAD) using data from The Cancer Genome Atlas (TCGA) database. To complement these findings, we measured the expression levels of TXNIP, glutathione peroxidase 4(GPX4), nuclear receptor coactivator 4 (NCOA4) in LUAD tissues through immunohistochemistry (IHC) staining.

RESULTS

A total of 651 DEGs were identified, with 17 of them being ferroptosis-related DEGs. These seventeen genes were categorized into four groups: driver genes, suppressor genes, unclassified genes, and inducer genes. Enrichment analysis revealed significant associations with oxidative stress, cell differentiation, tissue development, and cell death processes. The RNA-seq analysis demonstrated consistent gene expression patterns with protein expression, as evidenced by mass spectrometry analysis. Among the identified genes, SFN and TXNIP were singled out as hub genes, with TXNIP showing particularly noteworthy expression. The expression of the ferroptosis-related gene TXNIP exhibited correlations with the presence of an immunosuppressive microenvironment, TNM stages, and the degree of histological differentiation.Also, the ferroptosis-markers GPX4 and NCOA4 displayed correlations with LUAD. This comprehensive analysis underscores the significance of TXNIP in the context of ferroptosis-related processes and their potential implications in cancer development and progression.

CONCLUSION

The investigation conducted in this study systematically delved into the role of the ferroptosis-related gene TXNIP in Lung CSCs. The identification of TXNIP as a potentially valuable biomarker in this context could have significant implications for refining prognostic assessments and optimizing therapeutic strategies for advanced lung cancer.

摘要

背景

肺癌是全球癌症相关死亡的首要原因。癌症干细胞(CSCs)的存在带来了挑战,使当前的靶向肿瘤治疗无效。本研究致力于探索一种专注于铁死亡的新型治疗方法,并深入研究肺癌干细胞中铁死亡相关基因的表达。

方法

我们系统地检查了先前研究中从肺肿瘤细胞(LTCs)和肺癌干细胞(LSCs)获得的RNA测序数据集。我们的重点是分析与铁死亡相关的差异表达基因(DEGs)。利用京都基因与基因组百科全书(KEGG)和基因本体论(GO),我们对这些与铁死亡相关的DEGs进行了功能分析。此外,我们利用蛋白质-蛋白质相互作用网络来识别枢纽基因。对LTCs和LSCs进行液相色谱-串联质谱(LC-MS/MS)分析,以确定关键的铁死亡相关基因——硫氧还蛋白相互作用蛋白(TXNIP)。此外,我们深入研究了LTCs和LSCs的免疫细胞浸润情况,使用来自癌症基因组图谱(TCGA)数据库的数据研究TXNIP与肺腺癌(LUAD)之间的相关性。为了补充这些发现,我们通过免疫组织化学(IHC)染色测量了LUAD组织中TXNIP、谷胱甘肽过氧化物酶4(GPX4)、核受体辅激活因子4(NCOA4)的表达水平。

结果

共鉴定出651个DEGs,其中17个是与铁死亡相关的DEGs。这17个基因分为四组:驱动基因、抑制基因、未分类基因和诱导基因。富集分析显示与氧化应激、细胞分化、组织发育和细胞死亡过程有显著关联。RNA测序分析表明基因表达模式与蛋白质表达一致,质谱分析证明了这一点。在鉴定出的基因中,SFN和TXNIP被选为枢纽基因,其中TXNIP的表达尤其值得注意。铁死亡相关基因TXNIP的表达与免疫抑制微环境的存在、TNM分期和组织学分化程度相关。此外,铁死亡标志物GPX4和NCOA4与LUAD相关。这一综合分析强调了TXNIP在铁死亡相关过程中的重要性及其在癌症发展和进展中的潜在意义。

结论

本研究进行的调查系统地深入探讨了铁死亡相关基因TXNIP在肺癌干细胞中的作用。在这种情况下,将TXNIP鉴定为潜在有价值的生物标志物可能对完善晚期肺癌的预后评估和优化治疗策略具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/d6038c65aae4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/be221188df45/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/83477df8978e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/6857abb41ff8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/53fb4b7798d1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/c5214535d21e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/d6038c65aae4/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/be221188df45/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/83477df8978e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/6857abb41ff8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/53fb4b7798d1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/c5214535d21e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/625c/11033204/d6038c65aae4/gr6.jpg

相似文献

1
Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics.基于多组学的铁死亡相关基因TXNIP在肺腺癌干细胞中的诊断及预测意义
Transl Oncol. 2024 Jul;45:101926. doi: 10.1016/j.tranon.2024.101926. Epub 2024 Apr 13.
2
Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.用于预测肺腺癌总生存期的铁死亡相关基因特征的开发与验证
Front Cell Dev Biol. 2021 Jul 7;9:684259. doi: 10.3389/fcell.2021.684259. eCollection 2021.
3
Identifies microtubule-binding protein as a novel cancer biomarker associated with ferroptosis and tumor microenvironment.鉴定微管结合蛋白为一种与铁死亡和肿瘤微环境相关的新型癌症生物标志物。
Comput Struct Biotechnol J. 2022 Jun 24;20:3322-3335. doi: 10.1016/j.csbj.2022.06.046. eCollection 2022.
4
Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.利用生物信息学方法鉴定 CDT1 作为人肺腺癌的预后标志物。
PeerJ. 2023 Sep 28;11:e16166. doi: 10.7717/peerj.16166. eCollection 2023.
5
Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.铁死亡与WDFY4作为肺腺癌免疫治疗的新靶点。
Aging (Albany NY). 2023 Sep 19;15(18):9676-9694. doi: 10.18632/aging.205042.
6
Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma.一种用于肺腺癌的新型铁死亡相关预后标志物的构建与验证
Transl Lung Cancer Res. 2023 Aug 30;12(8):1766-1781. doi: 10.21037/tlcr-23-351. Epub 2023 Aug 28.
7
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
8
Identification and validation of a ferroptosis-related prognostic risk-scoring model and key genes in small cell lung cancer.小细胞肺癌中铁死亡相关预后风险评分模型及关键基因的鉴定与验证
Transl Lung Cancer Res. 2022 Jul;11(7):1380-1393. doi: 10.21037/tlcr-22-408.
9
Identification and Validation of Potential Ferroptosis-Related Genes in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.鉴定和验证糖皮质激素性股骨头坏死中潜在的铁死亡相关基因。
Medicina (Kaunas). 2023 Feb 6;59(2):297. doi: 10.3390/medicina59020297.
10
A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.一种新的与铁死亡相关的基因模型用于肺腺癌的预后预测。
BMC Pulm Med. 2021 Jul 13;21(1):229. doi: 10.1186/s12890-021-01588-2.

引用本文的文献

1
Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets.拓宽视野:肺癌中铁死亡的研究及其潜在治疗靶点
Front Immunol. 2025 Jan 23;16:1542844. doi: 10.3389/fimmu.2025.1542844. eCollection 2025.